Director Of FDA’s Center For Drug Evaluation And Research To Introduce New Office Of Pharmaceutical Quality At DIA Annual Meeting
3/17/2014 8:45:39 AM
The U.S. Food and Drug Administration’s (FDA) Janet Woodcock will lead a discussion of the mission and function of FDA’s new Office of Pharmaceutical Quality at the DIA 2014 50th Annual Meeting in San Diego, to be held June 15 to 19.
Woodcock is director of FDA’s Center for Drug Evaluation and Research (CDER), which regulates over-the-counter and prescription drugs, including biological therapeutics and generics. The recently established Office of Pharmaceutical Quality is tasked with enforcing existing quality standards throughout the lifecycle of a drug.
Help employers find you! Check out all the jobs and post your resume.
comments powered by